287 results
Page 6 of 15
8-K
EX-99.1
hsj2vh9
1 Jun 21
VBI Vaccines to Participate in Upcoming Investor Conferences
8:30am
8-K
EX-99.1
9pm4a fos2y
21 May 21
VBI Vaccines Announces $12 Million Second Tranche of Debt Financing with K2 HealthVentures
8:00am
8-K
EX-99.1
0jln119fve783s5ry1
20 May 21
VBI Vaccines to Present Updated Phase 2a Tumor Response and Overall Survival Data for VBI-1901 in Recurrent GBM at 2021 ASCO Annual Meeting
8:00am
8-K
EX-99.1
e6hgt
12 May 21
Regulation FD Disclosure
8:00am
8-K
EX-99.1
am8nvw1wxm dv5qgraxt
10 May 21
VBI Vaccines Announces First Quarter 2021 Financial Results and Provides Corporate Update
8:00am
8-K
EX-99.1
kskno3fk75zaukcj97j
3 May 21
VBI Vaccines Announces Multiple Presentations at the Canadian Liver Meeting 2021
9:00am
8-K
EX-99.1
qryovh
28 Apr 21
Regulation FD Disclosure
8:00am
8-K
EX-99.1
foy4aonc3
27 Apr 21
VBI Vaccines to Participate in National Securities Corporation’s Biotech Investor Summit
9:31am
8-K
EX-99.1
iz6b0ar8d6k2aip
26 Apr 21
VBI Vaccines Announces Presentation at the 2021 Annual Conference on About Hepatitis B
8:00am
8-K
EX-99.1
kyr1as
21 Apr 21
Regulation FD Disclosure
8:00am
8-K
EX-99.1
m73562hqpmbg491
12 Apr 21
VBI Vaccines Announces Phase 1b/2a Data and Progress of Hepatitis B Immunotherapeutic Candidate
8:00am
8-K
EX-99.1
pd3af0
15 Mar 21
VBI Vaccines to Present at Oppenheimer 31st Annual Healthcare Conference
8:00am
8-K
EX-99.1
sizn5rf
10 Mar 21
VBI Vaccines Announces Initiation of Enrollment in Adaptive Phase 1/2 Study of Prophylactic COVID-19 Vaccine Candidate, VBI-2902
7:38am
8-K
EX-99.2
p7gnqw2jhrw5
10 Mar 21
VBI Vaccines Announces Initiation of Enrollment in Adaptive Phase 1/2 Study of Prophylactic COVID-19 Vaccine Candidate, VBI-2902
7:38am
8-K
EX-99.1
rz68k
2 Mar 21
VBI Vaccines Reports Fourth Quarter and Full Year Financial Results for 2020, Provides Corporate Update and Outlook for 2021
8:00am
8-K
EX-99.1
ej88y5 jdmg67w
1 Mar 21
VBI Vaccines to Present at the Raymond James 42nd Annual Institutional Investors Conference
8:00am
8-K
EX-99.1
cyhbyfbxw p5pdr
2 Feb 21
VBI Vaccines Announces U.S. FDA Acceptance of BLA Filing for VBI’s 3-Antigen Prophylactic Hepatitis B Vaccine
8:21am